Contribution of intestinal barrier damage, microbial translocation and HIV-1 infection status to an inflammaging signature

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Steele, Amanda K ^a   Lee, Eric J ^a   Vestal, Brian ^b   Hecht, Daniel ^a   Dong, Zachary ^a   Rapaport, Eric ^a   Koeppe, John ^a   Campbell, Thomas B ^a   Wilson, Cara C ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CD14 ANTIGEN; CD27 ANTIGEN; FATTY ACID BINDING PROTEIN 2; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; BIOLOGICAL MARKER;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CD4+ T LYMPHOCYTE; CLUSTER ANALYSIS; CONTROLLED STUDY; CORRELATIONAL STUDY; DIGESTIVE SYSTEM INFLAMMATION; DISEASE CLASSIFICATION; FEMALE; FRAMINGHAM RISK SCORE; GASTROINTESTINAL MUCOSA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPHENOTYPING; INTESTINAL EPITHELIAL BARRIER DAMAGE; INTESTINE INJURY; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; VERY ELDERLY; VIRUS LOAD; ADOLESCENT; AGING; BACTERIUM; BLOOD; COMPLICATION; GENE EXPRESSION REGULATION; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; INFLAMMATION; INTESTINE MUCOSA; METABOLISM; MICROBIOLOGY; MIDDLE AGED; MOVEMENT (PHYSIOLOGY); PATHOLOGY; PHENOTYPE; PHYSIOLOGY; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGING; BACTERIA; BIOMARKERS; GENE EXPRESSION REGULATION; HIV INFECTIONS; HIV-1; HUMANS; INFLAMMATION; INTESTINAL MUCOSA; MALE; MIDDLE AGED; MOVEMENT; PHENOTYPE; YOUNG ADULT;

EID: 84901258066     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097171     Document Type: Article

References (54)

1. Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, et al. (2007) Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev 128: 92-105. (Pubitemid 46073065)
2. Yaffe K, Lindquist K, Penninx BW, Simonsick EM, Pahor M, et al. (2003) Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology 61: 76-80. (Pubitemid 36818750)
3. Cesari M, Penninx BW, Newman AB, Kritchevsky SB, Nicklas BJ, et al. (2003) Inflammatory markers and cardiovascular disease (The Health, Aging and Body Composition [Health ABC] Study). Am J Cardiol 92: 522-528. (Pubitemid 37013402)
4. Penninx BW, Kritchevsky SB, Newman AB, Nicklas BJ, Simonsick EM, et al. (2004) Inflammatory markers and incident mobility limitation in the elderly. J Am Geriatr Soc 52: 1105-1113. (Pubitemid 38869069)
5. Il'yasova D, Colbert LH, Harris TB, Newman AB, Bauer DC, et al. (2005) Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort. Cancer Epidemiol Biomarkers Prev 14: 2413-2418. (Pubitemid 41437845)
6. Reiner AP, Lange EM, Jenny NS, Chaves PH, Ellis J, et al. (2013) Soluble CD14: genomewide association analysis and relationship to cardiovascular risk and mortality in older adults. Arterioscler Thromb Vasc Biol 33: 158-164.
7. Ferrando-Martinez S, Romero-Sanchez MC, Solana R, Delgado J, de la Rosa R, et al. (2013) Thymic function failure and C-reactive protein levels are independent predictors of all-cause mortality in healthy elderly humans. Age (Dordr) 35: 251-259.
8. Simanek AM, Dowd JB, Pawelec G, Melzer D, Dutta A, et al. (2011) Seropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular disease-related mortality in the United States. PLoS One 6: e16103.
9. Larbi A, Franceschi C, Mazzatti D, Solana R, Wikby A, et al. (2008) Aging of the immune system as a prognostic factor for human longevity. Physiology (Bethesda) 23: 64-74.
10. Deeks SG (2011) HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med 62: 141-155.
11. Neuhaus J, Jacobs DR Jr, Baker JV, Calmy A, Duprez D, et al. (2010) Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis 201: 1788-1795.
12. Erlandson KM, Allshouse AA, Jankowski CM, Lee EJ, Rufner KM, et al. (2013) Association of Functional Impairment with Inflammation and Immune Activation in HIV Type 1-Infected Adults Receiving Effective Antiretroviral Therapy. J Infect Dis 208: 249-259.
13. McDonald B, Moyo S, Gabaitiri L, Gaseitsiwe S, Bussmann H, et al. (2013) Persistently elevated serum interleukin-6 predicts mortality among adults receiving combination antiretroviral therapy in Botswana: results from a clinical trial. AIDS Res Hum Retroviruses 29: 993-999.
14. High KP, Brennan-Ing M, Clifford DB, Cohen MH, Currier J, et al. (2012) HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr 60 Suppl 1: S1-18.
15. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, et al. (2006) Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 12: 1365-1371. (Pubitemid 44924494)
16. Mavigner M, Cazabat M, Dubois M, L'Faqihi FE, Requena M, et al. (2012) Altered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals. J Clin Invest 122: 62-69.
17. Vesterbacka J, Nowak P, Barqasho B, Abdurahman S, Nystrom J, et al. (2013) Kinetics of microbial translocation markers in patients on efavirenz or lopinavir/ r based antiretroviral therapy. PLoS One 8: e55038.
18. Ferguson JF, Patel PN, Shah RY, Mulvey CK, Gadi R, et al. (2013) Race and gender variation in response to evoked inflammation. J Transl Med 11: 63.
19. Cassol E, Malfeld S, Mahasha P, van der Merwe S, Cassol S, et al. (2010) Persistent microbial translocation and immune activation in HIV-1-infected South Africans receiving combination antiretroviral therapy. J Infect Dis 202: 723-733.
20. Pedersen KK, Pedersen M, Gaardbo JC, Ronit A, Hartling HJ, et al. (2013) Persisting inflammation and chronic immune activation but intact cognitive function in HIV-infected patients after long-term treatment with combination antiretroviral therapy. J Acquir Immune Defic Syndr 63: 272-279.
21. Reus S, Portilla J, Sanchez-Paya J, Giner L, Frances R, et al. (2013) Low-level HIV viremia is associated with microbial translocation and inflammation. J Acquir Immune Defic Syndr 62: 129-134.
22. De Milito A, Aleman S, Marenzi R, Sonnerborg A, Fuchs D, et al. (2002) Plasma levels of soluble CD27: a simple marker to monitor immune activation during potent antiretroviral therapy in HIV-1-infected subjects. Clin Exp Immunol 127: 486-494. (Pubitemid 34437820)
23. Chironi G, Simon A, Megnien JL, Sirieix ME, Mousseaux E, et al. (2011) Impact of coronary artery calcium on cardiovascular risk categorization and lipid-lowering drug eligibility in asymptomatic hypercholesterolemic men. Int J Cardiol 151: 200-204.
24. Tran L, Greenwood-Van Meerveld B (2013) Age-associated remodeling of the intestinal epithelial barrier. J Gerontol A Biol Sci Med Sci 68: 1045-1056.
25. Dillon SM, Manuzak JA, Leone AK, Lee EJ, Rogers LM, et al. (2012) HIV-1 infection of human intestinal lamina propria CD4+ T cells in vitro is enhanced by exposure to commensal Escherichia coli. J Immunol 189: 885-896.
26. Howe R, Dillon S, Rogers L, McCarter M, Kelly C, et al. (2009) Evidence for dendritic cell-dependent CD4(+) T helper-1 type responses to commensal bacteria in normal human intestinal lamina propria. Clin Immunol 131: 317-332.
27. Hand TW, Dos Santos LM, Bouladoux N, Molloy MJ, Pagan AJ, et al. (2012) Acute gastrointestinal infection induces long-lived microbiota-specific T cell responses. Science 337: 1553-1556.
28. Hearps AC, Martin GE, Angelovich TA, Cheng WJ, Maisa A, et al. (2012) Aging is associated with chronic innate immune activation and dysregulation of monocyte phenotype and function. Aging Cell 11: 867-875.
29. Leng SX, Tian X, Matteini A, Li H, Hughes J, et al. (2011) IL-6-independent association of elevated serum neopterin levels with prevalent frailty in community-dwelling older adults. Age Ageing 40: 475-481.
30. Qian F, Wang X, Zhang L, Chen S, Piecychna M, et al. (2012) Age-associated elevation in TLR5 leads to increased inflammatory responses in the elderly. Aging Cell 11: 104-110.
31. Merino A, Buendia P, Martin-Malo A, Aljama P, Ramirez R, et al. (2011) Senescent CD14+CD16+ monocytes exhibit proinflammatory and proatherosclerotic activity. J Immunol 186: 1809-1815.
32. Manuzak J, Dillon S, Wilson C (2012) Differential interleukin-10 (IL-10) and IL-23 production by human blood monocytes and dendritic cells in response to commensal enteric bacteria. Clin Vaccine Immunol 19: 1207-1217.
33. Manuzak JA, Dillon SM, Lee EJ, Dong ZM, Hecht DK, et al. (2013) Increased E. coli-induced IL-23 production by CD16+ monocytes correlates with systemic immune activation in untreated HIV-1 infected individuals. J Virol.
34. Haddad F, Zaldivar F, Cooper DM, Adams GR (2005) IL-6-induced skeletal muscle atrophy. J Appl Physiol 98: 911-917. (Pubitemid 40283672)
35. Vary TC, Deiter G, Lang CH (2006) Cytokine-triggered decreases in levels of phosphorylated eukaryotic initiation factor 4G in skeletal muscle during sepsis. Shock 26: 631-636. (Pubitemid 44789640)
36. del Campo R, Martinez E, del Fresno C, Alenda R, Gomez-Pina V, et al. (2011) Translocated LPS might cause endotoxin tolerance in circulating monocytes of cystic fibrosis patients. PLoS One 6: e29577.
37. Mirani M, Elenkov I, Volpi S, Hiroi N, Chrousos GP, et al. (2002) HIV-1 protein Vpr suppresses IL-12 production from human monocytes by enhancing glucocorticoid action: potential implications of Vpr coactivator activity for the innate and cellular immunity deficits observed in HIV-1 infection. J Immunol 169: 6361-6368. (Pubitemid 36903484)
38. Yim HC, Li JC, Lau JS, Lau AS (2009) HIV-1 Tat dysregulation of lipopolysaccharide-induced cytokine responses: microbial interactions in HIV infection. Aids 23: 1473-1484.
39. Han J, Wang B, Han N, Zhao Y, Song C, et al. (2009) CD14(high)CD16(+) rather than CD14(low)CD16 (+) monocytes correlate with disease progression in chronic HIV-infected patients. J Acquir Immune Defic Syndr 52: 553-559.
40. Wikby A, Johansson B, Olsson J, Lofgren S, Nilsson BO, et al. (2002) Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: the Swedish NONA immune study. Exp Gerontol 37: 445-453. (Pubitemid 34073563)
41. Blanco JR, Caro AM, Perez-Cachafeiro S, Gutierrez F, Iribarren JA, et al. (2010) HIV infection and aging. AIDS Rev 12: 218-230.
42. Lohse N, Hansen AB, Pedersen G, Kronborg G, Gerstoft J, et al. (2007) Survival of persons with and without HIV infection in Denmark, 1995-2005. Ann Intern Med 146: 87-95. (Pubitemid 351640011)
43. Hsue PY, Deeks SG, Hunt PW (2012) Immunologic basis of cardiovascular disease in HIV-infected adults. J Infect Dis 205 Suppl 3: S375-382.
44. Georges JL, Rupprecht HJ, Blankenberg S, Poirier O, Bickel C, et al. (2003) Impact of pathogen burden in patients with coronary artery disease in relation to systemic inflammation and variation in genes encoding cytokines. Am J Cardiol 92: 515-521. (Pubitemid 37013401)
45. Pedersen KK, Pedersen M, Troseid M, Gaardbo JC, Lund TT, et al. (2013) Microbial Translocation in HIV Infection is Associated with Dyslipidemia, Insulin Resistance, and Risk of Myocardial Infarction. J Acquir Immune Defic Syndr.
46. Hsue PY, Hunt PW, Sinclair E, Bredt B, Franklin A, et al. (2006) Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses. Aids 20: 2275-2283. (Pubitemid 44789529)
47. Lo J, Abbara S, Shturman L, Soni A, Wei J, et al. (2010) Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men. Aids 24: 243-253.
48. Karlamangla AS, Singer BH, McEwen BS, Rowe JW, Seeman TE (2002) Allostatic load as a predictor of functional decline. MacArthur studies of successful aging. J Clin Epidemiol 55: 696-710.
49. Wikby A, Johansson B, Ferguson F, Olsson J (1994) Age-related changes in immune parameters in a very old population of Swedish people: a longitudinal study. Exp Gerontol 29: 531-541. (Pubitemid 24294545)
50. Wikby A, Mansson IA, Johansson B, Strindhall J, Nilsson SE (2008) The immune risk profile is associated with age and gender: findings from three Swedish population studies of individuals 20-100 years of age. Biogerontology 9: 299-308.
51. Loke P, Favre D, Hunt PW, Leung JM, Kanwar B, et al. (2010) Correlating cellular and molecular signatures of mucosal immunity that distinguish HIV controllers from noncontrollers. Blood 115: e20-32.
52. Kamat A, Misra V, Cassol E, Ancuta P, Yan Z, et al. (2012) A plasma biomarker signature of immune activation in HIV patients on antiretroviral therapy. PLoS One 7: e30881.
53. Benjamini Y, Hochberg Y (1995) Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society Series B 57: 11.
54. Saldanha AJ (2004) Java Treeview-extensible visualization of microarray data. Bioinformatics 20: 3246-3248.